BerGenBio ASA (0RU5.L)

NOK 9.0

(-0.03%)

EBITDA Summary of BerGenBio ASA

BerGenBio ASA's latest annual EBITDA in 2023 was -191.8 Million NOK , up 36.99% from previous year.
BerGenBio ASA's latest quarterly EBITDA in 2024 Q2 was -51.76 Million NOK , down -40.53% from previous quarter.
BerGenBio ASA reported an annual EBITDA of -300.91 Million NOK in 2022, up 2.3% from previous year.
BerGenBio ASA reported an annual EBITDA of -307.99 Million NOK in 2021, down -20.18% from previous year.
BerGenBio ASA reported a quarterly EBITDA of -51.76 Million NOK for 2024 Q2, down -40.53% from previous quarter.
BerGenBio ASA reported a quarterly EBITDA of N/A for 2023 FY, up 36.99% from previous quarter.

Annual EBITDA Chart of BerGenBio ASA (2023 - 2014)

Historical Annual EBITDA of BerGenBio ASA (2023 - 2014)

Year	EBITDA	EBITDA Growth
2023	-191.8 Million NOK	36.99%
2022	-300.91 Million NOK	2.3%
2021	-307.99 Million NOK	-20.18%
2020	-260.92 Million NOK	-29.18%
2019	-198.38 Million NOK	-3.6%
2018	-191.54 Million NOK	-5.23%
2017	-183.51 Million NOK	-40.46%
2016	-131.36 Million NOK	-80.78%
2015	-72.74 Million NOK	-27.21%
2014	-57.5 Million NOK	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-40.76 Million NOK	30.29%
2024 Q2	-51.76 Million NOK	-40.53%
2023 FY	- NOK	36.99%
2023 Q3	-23.9 Million NOK	47.75%
2023 Q2	-45.74 Million NOK	33.99%
2023 Q1	-69.3 Million NOK	18.71%
2023 Q4	-50.64 Million NOK	-111.87%
2022 Q3	-55.86 Million NOK	31.83%
2022 Q1	-77.84 Million NOK	-5.45%
2022 FY	- NOK	2.3%
2022 Q4	-85.25 Million NOK	-52.59%
2022 Q2	-81.95 Million NOK	-5.28%
2021 Q2	-87.4 Million NOK	-11.03%
2021 FY	- NOK	-20.18%
2021 Q4	-73.82 Million NOK	-8.48%
2021 Q3	-68.05 Million NOK	22.13%
2021 Q1	-78.71 Million NOK	6.4%
2020 Q3	-63.64 Million NOK	-4.33%
2020 Q2	-60.99 Million NOK	-28.32%
2020 Q1	-47.53 Million NOK	22.26%
2020 FY	- NOK	-29.18%
2020 Q4	-84.1 Million NOK	-32.15%
2019 Q3	-43.11 Million NOK	14.21%
2019 FY	- NOK	-3.6%
2019 Q4	-61.14 Million NOK	-41.82%
2019 Q2	-50.26 Million NOK	-14.59%
2019 Q1	-43.86 Million NOK	15.12%
2018 Q2	-49.05 Million NOK	8.62%
2018 Q1	-53.68 Million NOK	-9.12%
2018 FY	- NOK	-5.23%
2018 Q4	-51.67 Million NOK	-39.35%
2018 Q3	-37.08 Million NOK	24.4%
2017 Q2	-33.25 Million NOK	48.54%
2017 Q1	-64.62 Million NOK	-127.45%
2017 FY	- NOK	-40.46%
2017 Q4	-49.19 Million NOK	-40.91%
2017 Q3	-34.91 Million NOK	-5.0%
2016 FY	- NOK	-80.78%
2016 Q4	-28.41 Million NOK	-87.2%
2016 Q3	-15.17 Million NOK	76.96%
2016 Q2	-65.88 Million NOK	0.0%
2015 FY	- NOK	-27.21%
2014 FY	- NOK	0.0%

Peer EBITDA Comparison of BerGenBio ASA

Name	EBITDA	EBITDA Difference
Photocure ASA	63.75 Million NOK	400.844%